These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 31733491)

  • 1. Heterogeneity in tumours: Validating the use of radiomic features on
    Krarup MMK; Nygård L; Vogelius IR; Andersen FL; Cook G; Goh V; Fischer BM
    Radiother Oncol; 2020 Mar; 144():72-78. PubMed ID: 31733491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG PET/CT Tumor Dissemination Characteristic Predicts the Outcome of First-Line Systemic Therapy in Non-small Cell Lung Cancer.
    Tan W; Zhang Y; Wang J; Zheng Z; Xing L; Sun X
    Acad Radiol; 2023 Dec; 30(12):2904-2912. PubMed ID: 37202226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity analysis of FDG PET tumor voxel cluster radiomics and dosimetry for predicting mid-chemoradiation regional response of locally advanced lung cancer.
    Duan C; Chaovalitwongse WA; Bai F; Hippe DS; Wang S; Thammasorn P; Pierce LA; Liu X; You J; Miyaoka RS; Vesselle HJ; Kinahan PE; Rengan R; Zeng J; Bowen SR
    Phys Med Biol; 2020 Oct; 65(20):205007. PubMed ID: 33027064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiblock Discriminant Analysis of Integrative
    Lee SH; Kao GD; Feigenberg SJ; Dorsey JF; Frick MA; Jean-Baptiste S; Uche CZ; Cengel KA; Levin WP; Berman AT; Aggarwal C; Fan Y; Xiao Y
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1451-1465. PubMed ID: 33662459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation.
    Thor M; Fitzgerald K; Apte A; Oh JH; Iyer A; Odiase O; Nadeem S; Yorke ED; Chaft J; Wu AJ; Offin M; Simone Ii CB; Preeshagul I; Gelblum DY; Gomez D; Deasy JO; Rimner A
    Radiother Oncol; 2024 Jan; 190():109983. PubMed ID: 37926331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts Tumor Immune Profiles in Non-Small Cell Lung Cancer: A Retrospective Multicohort Study.
    Tong H; Sun J; Fang J; Zhang M; Liu H; Xia R; Zhou W; Liu K; Chen X
    Front Immunol; 2022; 13():859323. PubMed ID: 35572597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promising Candidate Prognostic Biomarkers in [
    Hovhannisyan-Baghdasarian N; Luporsi M; Captier N; Nioche C; Cuplov V; Woff E; Hegarat N; Livartowski A; Girard N; Buvat I; Orlhac F
    J Nucl Med; 2024 Apr; 65(4):635-642. PubMed ID: 38453361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Functional Radiomics for Prediction of Cardiac Positron Emission Tomography Avidity in Lung Cancer Radiotherapy.
    Choi W; Jia Y; Kwak J; Werner-Wasik M; Dicker AP; Simone NL; Storozynsky E; Jain V; Vinogradskiy Y
    JCO Clin Cancer Inform; 2024 Mar; 8():e2300241. PubMed ID: 38452302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of PET/CT radiomic texture analysis of primary mass and mediastinal lymph node on survival in patients with non-small cell lung cancer.
    Agüloğlu N; Aksu A; Unat DS; Selim Unat Ö
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(5):500027. PubMed ID: 39029620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of segmentation algorithms on the measurement of
    Bashir U; Azad G; Siddique MM; Dhillon S; Patel N; Bassett P; Landau D; Goh V; Cook G
    EJNMMI Res; 2017 Dec; 7(1):60. PubMed ID: 28748524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitigating the impact of image processing variations on tumour [
    Ramlee S; Manavaki R; Aloj L; Escudero Sanchez L
    Sci Rep; 2024 Jul; 14(1):16294. PubMed ID: 39009706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between tumor heterogeneity and volume in cervical cancer: Evidence from integrated fluorodeoxyglucose 18 PET/MR texture analysis.
    Jin J; Wu K; Li X; Yu Y; Wang X; Sun H
    Nucl Med Commun; 2021 May; 42(5):545-552. PubMed ID: 33323868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Automated Method for Artifical Intelligence Assisted Diagnosis of Active Aortitis Using Radiomic Analysis of FDG PET-CT Images.
    Duff LM; Scarsbrook AF; Ravikumar N; Frood R; van Praagh GD; Mackie SL; Bailey MA; Tarkin JM; Mason JC; van der Geest KSM; Slart RHJA; Morgan AW; Tsoumpas C
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standard deviation of CT radiomic features among malignancies in each individual: prognostic ability in lung cancer patients.
    Hongwei S; Xinzhong H; Huiqin X; Shuqin X; Ruonan W; Li L; Jianzhong C; Sijin L
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7165-7173. PubMed ID: 36884114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Segmentation and Feature Extraction from Whole-Body FDG-PET/CT Using Cascaded 2D and 3D Convolutional Neural Networks.
    Jemaa S; Fredrickson J; Carano RAD; Nielsen T; de Crespigny A; Bengtsson T
    J Digit Imaging; 2020 Aug; 33(4):888-894. PubMed ID: 32378059
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of novel multi-level Otsu (MO-PET) and conventional PET segmentation methods for measuring FDG metabolic tumor volume in patients with soft tissue sarcoma.
    Lee I; Im HJ; Solaiyappan M; Cho SY
    EJNMMI Phys; 2017 Sep; 4(1):22. PubMed ID: 28921170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of CT radiomic features robust to acquisition and segmentation variations for improved prediction of radiotherapy-treated lung cancer patient recurrence.
    Louis T; Lucia F; Cousin F; Mievis C; Jansen N; Duysinx B; Le Pennec R; Visvikis D; Nebbache M; Rehn M; Hamya M; Geier M; Salaun PY; Schick U; Hatt M; Coucke P; Lovinfosse P; Hustinx R
    Sci Rep; 2024 Apr; 14(1):9028. PubMed ID: 38641673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Texture Features of
    Norikane T; Ishimura M; Mitamura K; Yamamoto Y; Arai-Okuda H; Manabe Y; Murao M; Morita R; Obata T; Tanaka K; Murota M; Kanaji N; Nishiyama Y
    J Clin Med; 2024 Mar; 13(6):. PubMed ID: 38541851
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept.
    Salehjahromi M; Karpinets TV; Sujit SJ; Qayati M; Chen P; Aminu M; Saad MB; Bandyopadhyay R; Hong L; Sheshadri A; Lin J; Antonoff MB; Sepesi B; Ostrin EJ; Toumazis I; Huang P; Cheng C; Cascone T; Vokes NI; Behrens C; Siewerdsen JH; Hazle JD; Chang JY; Zhang J; Lu Y; Godoy MCB; Chung C; Jaffray D; Wistuba I; Lee JJ; Vaporciyan AA; Gibbons DL; Gladish G; Heymach JV; Wu CC; Zhang J; Wu J
    Cell Rep Med; 2024 Mar; 5(3):101463. PubMed ID: 38471502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography-based assessment of metabolic gradient and other prognostic features in sarcoma.
    Wolsztynski E; O'Sullivan F; Keyes E; O'Sullivan J; Eary JF
    J Med Imaging (Bellingham); 2018 Apr; 5(2):024502. PubMed ID: 29845091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.